New pill shows promise for lowering blood pressure
NCT ID NCT00562614
First seen Apr 24, 2026 · Last updated May 21, 2026 · Updated 3 times
Summary
This study tested a new drug, SLx-2101, in 38 adults with moderate to severe high blood pressure. Participants took either 5 mg or 10 mg of the drug once a day for 14 days. The goal was to see if it safely lowers blood pressure and heart rate. The trial was a small, early-phase study to gather initial safety and effectiveness data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Parexel, Institute for Clinical Pharmacology
Berlin, D-14050, Germany
Conditions
Explore the condition pages connected to this study.